In a new clinical trial that could affect Hodgkin lymphoma (HL) treatments, researchers have reported a 92 percent survival rate among advanced-stage patients receiving a new immunotherapy regimen, potentially eliminating the need for radiation therapy and reducing long-term side effects commonly associated with traditional treatments.
This development marks a significant advancement in the fight against a type of cancer that predominantly affects younger people and those over 65.
Study Overview and Participant Diversity
Published in the New England Journal of Medicine on Wednesday, the trial indicates a potential shift in standard care for this rare but often deadly form of blood cancer.
Researchers enrolled nearly 1,000 patients from various cancer clinics and academic institutions across the United States and Canada. A key aspect of the trial was its inclusiveness: One-third of the participants were pediatric patients aged 12 and older, with 10 percent over 60. A quarter of the participants came from underrepresented demographics, addressing ongoing disparities in cancer treatment access and outcomes.
Participants were split into two groups: one received the standard treatment of chemotherapy with brentuximab vedotin, a drug that uses an antibody to deliver cancer-fighting medicine. The other group got the same treatment but also took nivolumab, a type of immunotherapy that helps the immune system target genetic changes linked to Hodgkin lymphoma. […]
— Read More: www.theepochtimes.com
At Last, a Company With Integrity in the Gold IRA Industry
For several years, I’ve been vetting out precious metals companies in search of the best. I believe in gold and silver but it’s hard to find integrity in the Gold IRA industry. The vast majority operate with shady tactics and gigantic spreads that take advantage of Americans who simply want to protect their life’s savings.
I’ve found a handful that I like and I’ve worked with some of them. By no means would I “unrecommend” them because, again, I vetted them out and found them to be above the fold. Unfortunately, it isn’t hard to be better than the rest when the rest are so darn awful.
After years of searching, I finally found a company that truly operates with integrity. Augusta Precious Metals has three important attributes that set them far above the competition:
- Non-Commissioned Sales Team: I cannot stress how important and unique this is. With just about every other company in the Gold IRA industry, the sales teams make commission from every account they open. This means they steer their clients toward the gold and silver products with the highest commission. With Augusta Precious Metals, the team is solely focused on putting the best gold and silver for their clients into their IRA. They get paid to serve the best interests of the Gold IRA client, NOT their own commission pay.
- Incredibly Low Fees: Most Americans would be shocked if they knew the spread other Gold IRA companies charge. Augusta charges just 5% versus up to 45% elsewhere.
- No Pressure, No Gimmicks: There’s an understanding among most in the Gold IRA industry that fear and pressure is the way to go. Augusta Precious Metals takes a sober approach when working with clients because they hold integrity in the highest possible regard. This is why they don’t offer gimmicks like “free” or “bonus” silver. It’s also why they do not apply pressure tactics to get quick sales. Their educational and transparent approach to doing business is exceedingly rare in the Gold IRA industry.
